Data-derived subtypes of delirium during critical illness.
Journal Information
Full Title: EBioMedicine
Abbreviation: EBioMedicine
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Genetics, Medical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"code sharing statement analysis code will be available on github ( https://github com/pitt-healthsciences/delirium_subtyping ) at the time of publication."
"Declaration of interests Kelly Potter acknowledges support from the National Institutes of Health (NIH). Jason Kennedy acknowledges support from the NIH. Niall Prendergast received funding from the NIH and receives authorship royalties from McGraw-Hill. Chukwudi Onyemekwu acknowledges support from the NIH. Wes Ely reports work with Eli Lily as an unfunded investigator on COVID-19 studies with Baricitinib and acknowledges VA and NIH grant support. Christopher Seymour receives research funding from the NIH, receives personal fees from Inotrem, Beckman–Coulter, and Octapharma, and is an Associate Editor for JAMA. Timothy Girard receives research funding from the NIH, the Department of Defense, and Ceribell and served previously on an advisory board for Lungpacer Medical Inc."
"This study was supported by the 10.13039/100000002National Institutes of Health (T32HL007820, R01AG027472). Kelly Potter acknowledges support from the National Institutes of Health (NIH). Jason Kennedy acknowledges support from the NIH. Niall Prendergast received funding from the NIH and receives authorship royalties from McGraw-Hill. Chukwudi Onyemekwu acknowledges support from the NIH. Wes Ely reports work with Eli Lily as an unfunded investigator on COVID-19 studies with Baricitinib and acknowledges VA and NIH grant support. Christopher Seymour receives research funding from the NIH, receives personal fees from Inotrem, Beckman–Coulter, and Octapharma, and is an Associate Editor for JAMA. Timothy Girard receives research funding from the NIH, the Department of Defense, and Ceribell and served previously on an advisory board for Lungpacer Medical Inc."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025